Inventor · Sayreville, NJ, US

Jonathan Brazaitis

9Patents
3h-index
3Co-inventors
42Inventor score

Filing activity: Mar 31, 2011 → Oct 6, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US8946150B2 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof Human Necessities 32 Active
US9169292B2 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof Human Necessities 32 Active
US9605027B2 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof Electricity 4 Active
US9868776B2 Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases Chemistry; Metallurgy 0 Active
US8618070B2 Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases Chemistry; Metallurgy 0 Active
US10416172B2 Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling Physics 0 Active
US9187750B2 Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases Chemistry; Metallurgy 0 Active
US9523073B2 Elisa for a naturally-occurring soluble truncated form of IL-23 receptor Physics 0 Active
USRE49026E1 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof General 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.